Closed
Last Update: May 26, 2026
Funding available
$ 750,000
Timeline
- Closing date : March 3, 2026
Location
Canada
Overview
SCN’s national research funding competition supports translational regenerative medicine research across the research continuum. It offers up to $750,000 for activities ranging from proof-of-principle studies to clinical trials and biotechnology partnerships.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Increase performance through digital transformation
- Develop strategic partnerships
- Develop a new product or service
Eligible Funding
- Maximum amount : 750,000 $
Timeline
- Closing date : March 3, 2026
Eligible candidates
Eligible Industries
- Professional, scientific and technical services
- Health care and social assistance
Location
- Canada
Legal structures
- Non-profit
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Non-profit candidates
Sector of operation
- Research
Target groups
- All the groups
Revenue structures
- All structures
Scope
- All dimensions
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Proof-of-principle experiments.
- Development of novel therapeutic or technical approaches.
- Knowledge creation and translation of regenerative medicine research.
- Multi-disciplinary research moving toward clinical use.
- Early-stage clinical trial projects and academic-industry partnerships.
Eligibility
Who is eligible?
- Academic research teams.
- Canadian regenerative medicine biotechnology companies.
- Academic-industry partnerships.
Processing and Agreement
- The competition includes a Letter of Intent stage.
- The listed Letter of Intent deadline has passed.
Additional information
- The program supports translational regenerative medicine research across the research continuum.
- Five funding streams are available under the competition.
- The maximum funding amount mentioned is $750,000.
Frequently Asked Questions about the Research Funding Programs Program
Here are answers to the most common questions about the Research Funding Programs. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.
What is the Research Funding Programs?
SCN’s national research funding competition supports translational regenerative medicine research across the research continuum. It offers up to $750,000 for activities ranging from proof-of-principle studies to clinical trials and biotechnology partnerships.
How much funding can be received?
Research Funding Programs Funds up to $750,000 of admissible expenses.
Who is eligible for the Research Funding Programs program?
To be eligible for the Research Funding Programs program, you must:
Project in regenerative medicine research.
Fits one funding stream.
May involve academic-industry partnership.
What expenses are eligible under Research Funding Programs?
Proof-of-principle experiments.
Development of novel therapeutic or technical approaches.
Knowledge creation and translation of regenerative medicine research.
Multi-disciplinary research moving toward clinical use.
Early-stage clinical trial projects and academic-industry partnerships.
Where is the Research Funding Programs available?
The Research Funding Programs program is available across Canada.
Is the Research Funding Programs a grant, loan, or tax credit?
Research Funding Programs is a Grant and Funding
Who are the financial supporters of the Research Funding Programs?
Research Funding Programs is funded by Stem Cell Network